Sally Wellinghoff Crawford's Insider Trades & SAST Disclosures
Sally Wellinghoff Crawford's most recent trade in ZimVie Inc was a trade of 11,012 Restricted Stock Units done . Disclosure was reported to the exchange on May 15, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Sally Wellinghoff Crawford.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ZimVie Inc | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 11,012 | 36,609 | - | - | Restricted Stock Units | |
| ZimVie Inc | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 500 | 6,255 | - | - | Deferred Share Units | |
| Hologic, Inc. | Sally Wellinghoff Crawford | Director | Sale of securities on an exchange or to another person at price $ 76.40 per share. | 07 Mar 2024 | 9,039 | 132,927 (0%) | 0% | 76.4 | 690,607 | Common Stock |
| Hologic, Inc. | Sally Wellinghoff Crawford | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.74 per share. | 07 Mar 2024 | 9,039 | 141,966 (0%) | 0% | 26.7 | 241,703 | Common Stock |
| Hologic, Inc. | Sally Wellinghoff Crawford | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 9,039 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 4,536 | 4,536 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 1,572 | 132,927 (0%) | 0% | - | Common Stock | |
| ZimVie Inc | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 762 | 5,755 | - | - | Deferred Share Units | |
| ZimVie Inc | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 17,704 | 25,597 | - | - | Restricted Stock Units | |
| ZimVie Inc | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 500 | 4,993 | - | - | Deferred Share Units | |
| ZimVie Inc | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 1,241 | 4,493 | - | - | Deferred Share Units | |
| ZimVie Inc | Sally Wellinghoff Crawford | Director | Purchase of securities on an exchange or from another person at price $ 5.60 per share. | 13 Mar 2023 | 40,000 | 40,127 | - | 5.6 | 224,120 | Common Stock |
| Hologic, Inc. | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 4,210 | 4,210 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 1,465 | 131,355 (0%) | 0% | - | Common Stock | |
| ZimVie Inc | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 957 | 3,251 | - | - | Deferred Share Units | |
| ZimVie Inc | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 870 | 2,294 | - | - | Deferred Share Units | |
| ZimVie Inc | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 541 | 1,423 | - | - | Deferred Share Units | |
| ZimVie Inc | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 7,893 | 7,893 | - | - | Restricted Stock Units | |
| ZimVie Inc | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 500 | 882 | - | - | Deferred Share Units | |
| ZimVie Inc | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 382 | 382 | - | - | Deferred Share Units | |
| Hologic, Inc. | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 5,293 | 5,293 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 1,565 | 129,890 (0%) | 0% | - | Common Stock | |
| Insulet Corporation | Sally Wellinghoff Crawford | Director | Sale of securities on an exchange or to another person at price $ 269.08 per share. | 04 Jun 2021 | 10,000 | 20,306 (0%) | 0% | 269.1 | 2,690,750 | Common Stock |
| Insulet Corporation | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 808 | 30,306 (0%) | 0% | 0 | Common Stock | |
| Hologic, Inc. | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 5,055 | 5,055 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Sally Wellinghoff Crawford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 1,478 | 128,325 (0%) | 0% | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges